<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE336nnn/GSE336897/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE336897</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Effect of peripheral kappa-opioid receptor agonists on murine T cells</name><description>This study investigated the transcriptional responses of murine T cell subsets to treatment with novel peripherally restricted, perhydroquinoxaline-derived kappa opioid receptor (KOR) agonists. We sorted and polarized primary murine CD4+ and CD8+ T cells towards Th1, Th17, Treg and CD8+ T cells and stimulated them with novel KOR agonists or vehicle control (DMSO). RNA sequencing was performed to assess gene expression changes associated with KOR activation across distinct T cell subsets.</description><dates><publication>2026/07/03</publication></dates><accession>GSE336897</accession><cross_references><GSM>GSM9844264</GSM><GSM>GSM9844253</GSM><GSM>GSM9844265</GSM><GSM>GSM9844254</GSM><GSM>GSM9844266</GSM><GSM>GSM9844255</GSM><GSM>GSM9844245</GSM><GSM>GSM9844267</GSM><GSM>GSM9844256</GSM><GSM>GSM9844268</GSM><GSM>GSM9844246</GSM><GSM>GSM9844257</GSM><GSM>GSM9844258</GSM><GSM>GSM9844247</GSM><GSM>GSM9844248</GSM><GSM>GSM9844259</GSM><GSM>GSM9844249</GSM><GSM>GSM9844260</GSM><GSM>GSM9844261</GSM><GSM>GSM9844250</GSM><GSM>GSM9844251</GSM><GSM>GSM9844262</GSM><GSM>GSM9844263</GSM><GSM>GSM9844252</GSM><GPL>34290</GPL><GSE>336897</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>